Project Grant R43AA032131
Award Date
5/15/25
Completion Date
4/30/27
Dollars Obligated
$132K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Awardee
Biomedit LLC (RJDQCPAH1HU4)
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
This $328,500 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research at Louisiana State University Health Sciences Center-Shreveport to investigate the role of lysophosphatidic acid (LPA) signaling in alcohol-induced blood-brain barrier disruption and neuroinflammation. The project aims to assess the effects of heavy alcohol consumption on mitochondrial function, redox balance, and the...
This federal Project Grant award of $510,412.27, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), will support research to investigate the role of the gut microbiota in alcohol seeking and reward-related decision-making. The University of Maryland, Baltimore will conduct this research using operant conditioning approaches in mouse models. The study aims to determine whether manipulating the gut microbiota using...
This Project Grant award, totaling $179,154, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award's objective is to elucidate novel mechanisms of alcohol-induced fibrotic gene reprogramming in the liver and identify specific factors amplifying hepatic stellate cell activation in alcohol-related liver disease. The awardee, the University of Colorado-Denver, will conduct research to...
The federal Project Grant award R01AA031226, totaling $523,477.00, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award supports a research project focused on studying alcohol-associated liver disease (ALD) and its interaction with the rs738409 genetic variant in the PNPLA3 gene, utilizing a human induced pluripotent stem cell (hiPSC)-derived multicellular liver culture model. The key...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support a study to evaluate the use of fecal microbiota transplantation (FMT) as a treatment for auto-brewery syndrome (ABS), a rare condition characterized by the production of ethanol in the gut. The total award amount is $498,080.00 and the project period runs from September 2024 to August 2026. The primary objectives are to assess the...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research to investigate the effects of alcohol consumption on RNA modifications and their contribution to the development and progression of alcohol-associated liver disease (ALD). The $374,598 award will fund a study that will map the chemical modifications on different types of RNAs isolated from the livers of mice treated with alcohol, and...
This Project Grant award, titled "CHIMERA-BONCAT: A NOVEL IN VIVO MODEL FOR IN-DEPTH CHARACTERIZATION OF THE HUMAN MICROGLIAL RESPONSE TO ALCOHOL", is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The $214,385 award will be used by the University of South Florida to develop a novel in vivo model called "CHIMERA-BONCAT" that will allow for comprehensive, unbiased, and...
This $119,600 Project Grant award, titled "LYSOSOME AND INTEGRATED STRESS RESPONSE IN AGING AND ALCOHOL-ASSOCIATED LIVER DISEASE", is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273). The award supports research aimed at identifying and understanding the mechanisms by which aging and alcohol consumption cooperatively contribute to the development of alcohol-associated liver disease (ALD). The research,...
The University of California, San Diego (UCSD) was awarded a $414,750 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) to investigate the role of intestinal gp130 signaling in preventing alcohol-associated liver disease. The proposed research aims to define the gp130-STAT3-Reg3 signaling axis involved in protecting against ethanol-induced liver disease and assess the potential of a novel engineered gp130...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $537,587 to The University of Texas Southwestern Medical Center to identify mechanisms through which interferon regulatory factor 3 (IRF3) suppresses fibroblast growth factor 21 (FGF21) expression and secretion, and determine the impact of this IRF3-FGF21 axis on alcohol consumption and alcohol-associated liver disease (ALD). The goal...